CureZone   Log On   Join
Re:
 
  Views: 4,340
Published: 16 y
 
This is a reply to # 1,151,694

Re:


Iodine works. They probably set that company up to fail from the onset, as a counterpoise to the Ghent-Easkin study which proved unequivocally, the alleviation of fibrocystic breast disease in over 96% of the hundreds of women participants in that placebo-controlled, double-blind study, at 12 mg a day.

There's a lot of variables here. I bet if one examined it, the BS could be quickly found. I wonder what Dr. Abraham would comment.

Given that when many starting Iodine take, one drop a day, and see flabbergasting effects, it's hard to fathom that people from a large group just jumped right in to 6 mg doses and reported no effect.

Sybil lyin's data set, is not consistent with the Curezone data set.

And if the CZ data set isn't friggin better than double blind, I don't know what is. People are free to write in here and say that Iodine is useless, etc. Yet the results reported by anonymous people, with no financial interest, have been quite the opposite.

My conclusion is that Sybil lyin was a ruse from the beginning.

The regulators knew or should have known that 12 mg works, from Ghent-Easkin, which no doubt, they would like to flush down the memory hole.

Since 12 mg was already shown efficacious and safe, there should have been no reasonable motivation to limit Sybil study solely to 6 mg. If the interests were human health, it would have been done at multiple dose levels.

Thinkin I need to quit writing this stuff. Does anybody really care ?








 

 
Printer-friendly version of this page Email this message to a friend
Alert Moderators
Report Spam or bad message  Alert Moderators on This GOOD Message

This Forum message belongs to a larger discussion thread. See the complete thread below. You can reply to this message!


 

Donate to CureZone


CureZone Newsletter is distributed in partnership with https://www.netatlantic.com


Contact Us - Advertise - Stats

Copyright 1999 - 2024  www.curezone.org

0.264 sec, (1)